| Catalog_no |
ADMC0955 |
| Product_name |
Vilanterol trifenatate |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
4000.00/9500.00/14780.00 |
| Specificity |
Target: Adrenergic Receptor . Fields: Vilanterol trifenatate (GW642444)is a novel, inhaled, long-acting β(2) agonist with inherent 24-h activity under development as a once-daily combination therapy with an inhaled corticosteroid for COPD and asthma. |
| Dilution |
pEC50: 10.37±0.05 (β2-adrenoceptor), 6.98±0.03 (β1-adrenoceptor), 7.36±0.03 (β3-adrenoceptor)[1] |
| Purification |
>98% |
| Concentration |
靶点：Adrenergic Receptor;IC50：pEC50: 10.37±0.05 (β2-adrenoceptor), 6.98±0.03 (β1-adrenoceptor), 7.36±0.03 (β3-adrenoceptor)[1] |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
GW642444M; GW 642444M; GW-642444M |
| Molecular Weight |
774.77 |
| Notes |
Vilanterol trifenatate (GW642444)is a novel, inhaled, long-acting β(2) agonist with inherent 24-h activity under development as a once-daily combination therapy with an inhaled corticosteroid for COPD and asthma. pEC50: 10.37±0.05 (β2-adrenoceptor), |
| Instructions |
 查看与下载 |
